FDA DEVICE FACTS
Avenir® Müller Stem; Avenir Complete™ Hip System
Zimmer, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Avenir® Müller Stem The Avenir Müller Uncemented Hip Stems are intended for cementless use in total or hemi hip arthroplasty and are indicated for the following conditions:
- Noninflammatory degenerative joint disease (NIDJD), e.g., avascular necrosis and osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis.
- Acute traumatic fracture of the femoral head or neck. Avenir Complete™ Hip System The Avenir Complete Hip System is intended for cementless use in total or hemi hip arthroplasty and is indicated in the following conditions:
- Advanced wear of the joint due to degenerative, post-traumatic or rheumatic diseases.
- Failed previous hip surgery including joint reconstruction (osteotomy), arthrodesis, hemi-arthroplasty or total hip replacement (THR).
- Acute traumatic fracture of the femoral head or neck.
- Avascular necrosis of the femoral head.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。